Corpus ID: 154413995

Starting on the right foot: Public consultation to inform issue definition in genome policy

  title={Starting on the right foot: Public consultation to inform issue definition in genome policy},
  author={Michael M Burgess},
This paper reports the first phase of a project to evaluate how different methods of applied ethics assess public interests in governing genomics and biotechnology. The objective was to select three topics and issues for further research in order to provide a practical context for a diverse range of public interests. Ten focus groups with and without direct interests in genetics and genomics were asked to characterize the field of genomics, their hopes and their concerns. Thematic analysis… Expand

Tables from this paper

Public consultation in ethics an experiment in representative ethics
  • M. Burgess
  • Political Science, Medicine
  • Journal of bioethical inquiry
  • 2004
A significant contribution of ethical dialogue strengthened by social analysis is to consider the context and non-policy use of power to govern genomics and to sustain social debate on enduring ethical issues. Expand
An Australian Approach to the Policy Translation of Deliberated Citizen Perspectives on Biobanking
Assessing the sufficiency of diversity in citizen representation was central to the deliberation-to-translation process and influenced policy substance and credibility among stakeholders and contributed to the state government directive that policy compliance be mandatory. Expand
Biobank governance: a lesson in trust
Biobanks are controversial due to their ethical, legal, and social implications. Recent discussion has highlighted a central role for governance in helping to address these controversies. We argueExpand
Public attitudes and values in priority setting
  • S. Peacock
  • Sociology, Medicine
  • Israel Journal of Health Policy Research
  • 2015
To better understand public attitudes and values relating to priority setting in health care, researchers and decision-makers will have to employ a range of quantitative and qualitative approaches, drawing on different disciplines and methodological traditions. Expand
Expert views on critical success and failure factors for nutrigenomics
Public adoption of new technologies is an important determinant for their success. In this paper we examined a specific case of new technology in the nutrition domain – nutrigenomics – theExpand
Priority setting of ICU resources in an influenza pandemic: a qualitative study of the Canadian public's perspectives
The findings underscore the importance of public consultation in pandemic planning for sustaining public trust in a public health emergency and policymakers may benefit from a better understanding the public's empirical and ethical 'starting points' in developing effective pandemic plans. Expand
Public acceptance of nutrigenomics-based personalised nutrition : exploring the future with experts and consumers
This thesis contributes to a better understanding of how public acceptance of the scientific innovation of nutrigenomics-based personalised nutrition comes about and shows how issues critical for the further development of such an emerging science and the innovations arising from it can be systematically identified and addressed. Expand
Evidence, values, and funding decisions in Canadian cancer systems
Recent developments in evidence-based approaches to priority setting and resource allocation in Canadian cancer systems include new methods for deliberative public engagement, generating and using real-world evidence, multi-criteria decision analysis, and handling uncertainty with evidence for gene therapies. Expand
Consumers and new food technologies
This paper aims to describe the current landscape in Europe within which emerging food technologies are developed and applied, and to give insights from other parts of the world. Consumers’ attitudesExpand
Consumer acceptance of nutrigenomics-based personalised nutrition
The present study develops a set of key hypotheses on public acceptance of personalised nutrition and tests these in a representative sample of Dutch consumers and provides guidance for the successful further development of nutrigenomics and its applications. Expand


The new genetics and health: mobilizing lay expertise
It is concluded that identifying lay people as expert in, rather than ignorant of, the way genetics may shape their lives is a fundamental first step in moving toward greater lay participation in policy discussions and, ultimately, decision making about the new genetics and health. Expand
Accountability for reasonableness
  • N. Daniels
  • Medicine
  • BMJ : British Medical Journal
  • 2000
The study found that transparency was important to participants in the decisions, though it did not state whether the rationales for decisions were then made transparent to all affected by them, and an ethical approach to fair process must build on their findings. Expand
Drawing the line: an analysis of lay people's discussions about the new genetics
Differences in the amount and type of information and advice available to clients of genetic testing, the level of social support to people with particular conditions, and people's perception of stigma, suffering, and quality of life, make drawing the line highly problematic. Expand
The commercialization of human genetics: profits and problems
Whether the commercialization of academic research is compromising academic freedom, progress in clinical research, and the authors' attitudes to normal good health is examined. Expand
The commercialization of human genetics: profits and problems.
Whether the commercialization of academic research is compromising academic freedom, progress in clinical research, and the authors' attitudes to normal good health is examined. Expand
Eugenics and the New Genetics in Britain: Examining Contemporary Professionals' Accounts
This article explores the accounts of eugenics made by a small but important group of British scientists and clinicians working on the new genetics as applied to human health and highlights the ambiguities and difficulties in professionals' use of this rhetoric. Expand
Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards.
The authors explore the commercialization of so-called breast cancer gene tests, based upon genetic alterations linked to the disease, and conclude that the present regulatory system is inadequate and places a dangerous amount of reliance on primary care physicians. Expand
Funding medical and health-related research in the public interest.
  • P. Baird
  • Business, Medicine
  • CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
  • 1996
Mechanisms need to be found to ensure an appropriate balance between the research that is most valuable to the public interest and to the long-term advancement of knowledge, and theResearch that is likely to lead to marketable products. Expand
‘There’s this thing in our family’: predictive testing and the construction of risk for Huntington Disease
Recent approaches to the new genetics stress the importance of placing hereditary risk within the context of familial beliefs and dynamics. Nonetheless, few empirical studies on predictive geneticExpand
Biotechnology: The Genomics Gamble
Drug companies, biotechs, and Wall Street investors are putting their money down on efforts to unlock the secrets of human DNA. But when will genomics deliver on its promise of next-generation drugsExpand